, Volume 10, Issue 2, pp 189–203

Aging and the growth hormone/insulin like growth factor-I axis



Growth hormone release and IGF-I synthesis decrease with increasing age. The regulation of the GH/IGF-I system is dependant on the integrity of the hypothalamus, pituitary and liver. During aging there are several changes which contribute to the decline in GH/IGF-I including changes in signal to the somatotrophs from growth hormone releasing hormone, somatostatin and other factors such as body composition, exercise, diet and sleep. All of these factors are discussed in detail within this review. The phenotypic similarities between aging and adult growth hormone deficiency syndrome combined with this decrease in GH/IGF-I with aging have prompted the question whether aging is a GH deficient state. The advent of recombinant growth hormone has led to a number of studies treating elderly patients with GH alone or in combination with sex steroids or exercise. The results of these studies would not back up the use of GH in elderly non-hypopituitary patients as they did not show efficacy, showed high rates of adverse events and there is also some evidence associating GH/IGF-I and risk of neoplasia. If GH therapy is to be used in this cohort of patients further long term efficacy and safety studies are required.


Aging GH/IGF-I Axis GH Treatment 


  1. 1.
    Hartman ML, Faria AC, Vance ML, Johnson ML, Thorner MO, Veldhuis JD (1991) Temporal structure of in vivo growth hormone secretory events in humans. Am J Physiol 260(1 Pt 1):E101–E110PubMedGoogle Scholar
  2. 2.
    Holl RW, Hartman ML, Veldhuis JD, Taylor WM, Thorner MO (1991) Thirty second sampling of plasma growth hormone in man: correlation with sleep stages. J Clin Endocrinol Metab 72:854–861PubMedGoogle Scholar
  3. 3.
    Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Rev 19(6):717–797Google Scholar
  4. 4.
    Fukata J, Diamond D, Martin J (1985) Effects of rat growth hormone releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells. Endocrinology 117:457–467PubMedGoogle Scholar
  5. 5.
    Reichlin S (1983) Somatostatin (part 1). N Engl J Med 309:1495–1501PubMedCrossRefGoogle Scholar
  6. 6.
    Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI et al (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273(5277):974–977PubMedGoogle Scholar
  7. 7.
    Smith RG, Sun Y, Betancourt L, Asnicar M (2004) Growth hormone secretagogues: prospects and potential pitfalls. Best Pract Res Clin Endocrinol Metab 18(3):333–347PubMedGoogle Scholar
  8. 8.
    Ballard J, Baxter R, Binoux M, Clemmons D, Drop S, Hall K et al (1989) On the nomenclature of the IGF binding proteins. Acta Endocrinologica (Copenhagen) 121(5):751–752Google Scholar
  9. 9.
    Wehrenberg WB, Brazeau P, Luben R, Bohlen P, Guillemin R (1982) Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology 111(6):2147–2148PubMedGoogle Scholar
  10. 10.
    Barinaga M, Yamonoto G, Rivier C, Vale W, Evans R, Rosenfeld MG (1983) Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature 306(5938):84–85PubMedGoogle Scholar
  11. 11.
    Thorner MO, Rivier J, Spiess J, Borges JL, Vance ML, Bloom SR et al (1983) Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man. Lancet 1(8314–5):24–28PubMedGoogle Scholar
  12. 12.
    Tannenbaum GS, Ling N (1984) The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 115(5):1952–1957PubMedGoogle Scholar
  13. 13.
    Hindmarsh PC, Brain CE, Robinson ICAF, Matthews DR, Brook CGD (1991) The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man. Clin Endocrinol 35:353–360Google Scholar
  14. 14.
    Plotsky PM, Vale W (1985) Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 230(4724):461–463PubMedGoogle Scholar
  15. 15.
    Frohman LA, Downs TR, Clarke IJ, Thomas GB (1990) Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia. J Clin Invest 86(1):17–24PubMedGoogle Scholar
  16. 16.
    Burton KA, Kabigting EB, Clifton DK, Steiner RA (1992) Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypothalamic somatostatin neurons. Endocrinology 131(2):958–963PubMedGoogle Scholar
  17. 17.
    Minami S, Kamegai J, Hasegawa O, Sugihara H, Okada K, Wakabayashi I (1993) Expression of growth hormone receptor gene in rat hypothalamus. J Neuroendocrinol 5(6):691–696PubMedGoogle Scholar
  18. 18.
    Sheppard MC, Kronheim S, Pimstone BL (1978) Stimulation by growth hormone of somatostatin release from the rat hypothalamus in vitro. Clin Endocrinol 9:583–586Google Scholar
  19. 19.
    Ross RJM, Borges F, Grossman A, Smith R, Ngahfoong L, Rees LH et al (1987) Growth hormone pretreatment in man blocks the response to growth hormone-releasing hormone; evidence for a direct effect of GH. Clin Endocrinol 26:117–123Google Scholar
  20. 20.
    Hartman ML, Clayton PE, Johnson ML, Celniker A, Perlman AJ, Alberti KGMM et al (1993) A low dose euglycaemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest 91:2453–2462PubMedGoogle Scholar
  21. 21.
    Yamashita S, Melmed S (1986) Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology 118(1):176–182PubMedGoogle Scholar
  22. 22.
    Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL (1981) Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212(4500):1279–1281PubMedGoogle Scholar
  23. 23.
    Aguila MC, Boggaram V, McCann SM (1993) Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels. Brain Res 625(2):213–218PubMedGoogle Scholar
  24. 24.
    Shibasaki T, Yamauchi N, Hotta M, Masuda A, Imaki T, Demura H et al (1986) In vitro release of growth hormone-releasing factor from rat hypothalamus: effect of insulin-like growth factor-1. Regul Pept 15(1):47–53PubMedGoogle Scholar
  25. 25.
    Martha PM Jr, Goorman KM, Blizzard RM, Rogol AD, Veldhuis JD (1992) Endogenous growth hormone secretion and clearance rates in normal boys as determined by deconvolutionaal analysis: relationship to age, pubertal status and body mass. J Clin Endocrinol Metab 74:336–344PubMedGoogle Scholar
  26. 26.
    Martha PM Jr, Rogol AD, Veldhuis JD, Blizzard RM (1996) A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. The neuroendocrine growth hormone axis during late puberty. J Clin Endocrinol Metab 81:4068–4074PubMedGoogle Scholar
  27. 27.
    Mauras N, Rogol AD, Haymond MW, Veldhuis JD (1996) Sex steroids, growth hormone, IGF-I: neuroendocrine and metabolic regulation in puberty. Hormone Res 45:74–80PubMedGoogle Scholar
  28. 28.
    Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP (1981) Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 67:1361–1369PubMedGoogle Scholar
  29. 29.
    Shibasaki T, Shizume K, Nakahara M, Masuda A, Jibiki K, Demurah et al (1984) Age related changes in plasma growth hormone response to growth hormone releasing factor in man. J Clin Endocrinol Metab 58:212–214PubMedGoogle Scholar
  30. 30.
    Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E et al (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51–58PubMedGoogle Scholar
  31. 31.
    Iranmanesh A, Lizarralde G, Veldhuis JD (1991) Age and relative obesity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081–1088PubMedGoogle Scholar
  32. 32.
    Weltman A, Weltman JY, Hartman ML, Abbott RD, Rogol AD, Evans WS et al (1994) Relationship between age, percentage body fat, fitness and 24-hour growth hormone release in healthy young adults: effect of gender. J Clin Endocrinol Metab 78:543–548PubMedGoogle Scholar
  33. 33.
    Rossi GL, Bestetti GE, Galbiati E, Muller EE, Cocchi D (1991) Sexually dimorphic effects of aging on rat somatotropes and lactotropes. J Gerontol 46(4):B152–B158PubMedGoogle Scholar
  34. 34.
    Ghigo E, Arvat E, Rizzi G, Bellone J, Nicolosi M, Boffano GM et al (1994) Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration. J Endocrinol Invest 17(3):157–162PubMedGoogle Scholar
  35. 35.
    Ghigo E, Goffi S, Nicolosi M, Arvat E, Valente F, Mazza E et al (1990) Growth hormone responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J Clin Endocrinol Metab 71:1481–1485PubMedGoogle Scholar
  36. 36.
    Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM, Templ H (1987) Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals. J Clin Endocrinol Metab 65:535–540PubMedGoogle Scholar
  37. 37.
    Muller EE, Cocchi D, Ghigo E, Arvat E, Locatelli V, Camanni F (1993) Growth hormone response to GHRH during lifespan. J Pediatr Endocrinol 6(1):5–13PubMedGoogle Scholar
  38. 38.
    van den Berg G, Veldhuis JD, Frolich M, Roelfsema F (1996) An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 81(7):2460–2467PubMedGoogle Scholar
  39. 39.
    Faria ACS, Bekenstein LW, Booth R Jr, Vaccaro VA, Asplin CM, Veldhuis JD et al (1992) Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol 36:591–596Google Scholar
  40. 40.
    Ovesen P, Vahl N, Fisker S, Veldhuis JD, Christiansen JS, Jorgensen JOL (1998) Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levles during periovulatory interval in normal women. J Clin Endocrinol Metab 83:1662–1667PubMedGoogle Scholar
  41. 41.
    Dawson-Hughes B, Stern D, Goldman J, Reichlin S (1986) Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of Physiological estrogen replacement. J Clin Endocrinol Metab 63:424–432PubMedCrossRefGoogle Scholar
  42. 42.
    Weissberger AJ, Ho KKY, Lazarus L (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone secretion, insulin-like growth factor I and GH binding protein in post-menopausal women. J Clin Endocrinol Metab 72:374–381PubMedGoogle Scholar
  43. 43.
    Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO (1996) Both oral and transdermal estrogen increase growth hormone release in postmenopausal women – a clinical research center study. J Clin Endocrinol Metab 81:2250–2256PubMedGoogle Scholar
  44. 44.
    Veldhuis JD, Metzger DL, Martha PM Jr, Mauras N, Kerrigan JR, Keenan B et al (1997) Estrogen and Testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor-I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82:3414–3420PubMedGoogle Scholar
  45. 45.
    Weissberger AJ, Ho KK (1993) Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab 76:1407–1412PubMedGoogle Scholar
  46. 46.
    Hickson M (2006) Malnutrition and ageing. Postgrad Med J 82(963):2–8PubMedGoogle Scholar
  47. 47.
    Clemmons DR, Underwood LE (1991) Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr 11:393–412PubMedGoogle Scholar
  48. 48.
    Hartman ML, Veldhuis JD, Johnson ML, Lee MM, Alberti KG, Samojlik E et al (1992) Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab 74(4):757–765PubMedGoogle Scholar
  49. 49.
    Imaki T, Shibasaki T, Shizume K, Masuda A, Hotta M, Kiyosawa Y et al (1985) The effect of free fatty acids on growth hormone-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 60:290–293PubMedGoogle Scholar
  50. 50.
    Hartman ML (2000) Physiological regulators of growth hormone secretion. In: Juul A, Jorgensen JOL (eds) Growth hormone in adults, 2nd edn. Cambridge University Press, Cambridge, pp 3–53Google Scholar
  51. 51.
    Baker HW, Best JB, Burger HG (1970) Arginine-infusion test for growth-hormone secretion. Lancet 2(7684):1193PubMedGoogle Scholar
  52. 52.
    Novak LP (1972) Aging, total body potassium, fat-free mass and cell mass in males and females between ages 18 and 85. J Gerontol 27:439–443Google Scholar
  53. 53.
    Forbes GB, Reina JC (1970) Adult lean body mass declines with age: some longitudinal observations. Metabolism 19:653–663PubMedGoogle Scholar
  54. 54.
    Borkan GA, Hults DE, Gerzof SG, Robbins AH, Silbert CK (1983) Age related changes in body composition revealed by computed tomography. J Gerontol 38:673–677PubMedGoogle Scholar
  55. 55.
    Veldhuis JD, Iranmanesh A, Ho KKY, Waters MJ, Johnson ML, Lizarralde G (1991) Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatropism of obesity in man. J Clin Endocrinol Metab 72:51–59PubMedCrossRefGoogle Scholar
  56. 56.
    Scacchi M, Pincelli AI, Cavagnini F (1999) Growth hormone in obesity. Int J Obes Relat Metab Disord 23(3):260–271PubMedGoogle Scholar
  57. 57.
    Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE et al (1995) Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 80(4):1407–1415PubMedGoogle Scholar
  58. 58.
    Clasey JL, Weltman A, Patrie J, Weltman JY, Pezzoli S, Bouchard C et al (2001) Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clin Endocrinol Metab 86(8):3845–3852PubMedGoogle Scholar
  59. 59.
    Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA et al (1995) Differential impact of age, sex steroid hormones and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80:3209–3222PubMedGoogle Scholar
  60. 60.
    Ghigo E, Procopio M, Boffano GM, Arvat E, Valente F, Maccario M et al (1992) Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metabolism 41(5):560–563PubMedGoogle Scholar
  61. 61.
    Ghigo E, Arvat E, Gianotti L, Ramunni J, Maccario M, Camanni F (1994) Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH stimulated GH secretion in humans. Clin Endocrinol 40:799–802Google Scholar
  62. 62.
    Van Cauter E, Kerkhofs M, Caufriez A, Van Onderbergen A, Thorner MO, Copinschi G (1992) A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab 74(6):1441–1450PubMedGoogle Scholar
  63. 63.
    Kerkhofs M, Van Cauter E, Van Onderbergen A, Caufriez A, Thorner MO, Copinschi G (1993) Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol 264(4 Pt 1):E594–E598PubMedGoogle Scholar
  64. 64.
    Van Cauter E, Plat L, Copinschi G (1998) Interrelations between sleep and the somatotropic axis. Sleep 21(6):553–566PubMedGoogle Scholar
  65. 65.
    Copinschi G, Leproult R, Van Onderbergen A, Caufriez A, Cole KY, Schilling LM et al (1997) Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology 66(4):278–286PubMedGoogle Scholar
  66. 66.
    Kamel NS, Gammack JK (2006) Insomnia in the elderly: cause, approach, and treatment. Am J Med 119(6):463–469PubMedGoogle Scholar
  67. 67.
    deJong AA, Franklin BA (2004) Prescribing exercise for the elderly: current research and recommendations. Curr Sports Med Rep 3(6):337–343PubMedGoogle Scholar
  68. 68.
    Felsing NE, Brasel JA, Cooper DM (1992) Effect of low and high intensity exercise on circulating growth hormone in men. J Clin Endocrinol Metab 75(1):157–162PubMedGoogle Scholar
  69. 69.
    Weltman A, Weltman JY, Schurrer R, Evans WS, Veldhuis JD, Rogol AD (1992) Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity. J Appl Physiol 72(6):2188–2196PubMedGoogle Scholar
  70. 70.
    Vahl N, Jorgensen JO, Jurik AG, Christiansen JS (1996) Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab 81(6):2209–2215PubMedGoogle Scholar
  71. 71.
    Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413–437PubMedGoogle Scholar
  72. 72.
    Reutens AT, Hoffman DM, Leung K-C, Ho KKY (1995) Evaluation and application of a highly sensative assay for serum growth hormone in the study of adult GH deficiency. J Clin Endocrinol Metab 80:480–485PubMedGoogle Scholar
  73. 73.
    Rose SR, Ross JL, Uriarte M, Barnes KM, Cassorla FG, Cutler GB (1988) The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Eng J Med 319:201–207CrossRefGoogle Scholar
  74. 74.
    Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KGMM et al (1988) Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81:968–975PubMedCrossRefGoogle Scholar
  75. 75.
    Barkan AL, Beitins IZ, Kelch RP (1988) Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 67(1):69–73PubMedCrossRefGoogle Scholar
  76. 76.
    Kalk WJ, Vinik AI, Pimstone BL, Jackson WP (1973) Growth hormone responses to to insulin hypoglycaemia in the elderly. J Gerontol 28:431–433PubMedGoogle Scholar
  77. 77.
    Muggeo M, Feddele D, Tiengo A, Molinari M, Crepaldi G (1975) Human growth hormone and cortisol responses to insulin stimulation in ageing. J Gerontol 30:546–551PubMedGoogle Scholar
  78. 78.
    Pavlov EP, Harman SM, Merriam GR, Gelato MC, Blackman MR (1986) Responses of growth hormone and somatomedin-C to GH-releasing hormone in healthy aging men. J Clin Endocrinol Metab 62:595–600PubMedGoogle Scholar
  79. 79.
    Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F (1996) New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 134:352–356PubMedCrossRefGoogle Scholar
  80. 80.
    Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C et al (2000) GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 356(9236):1137–1142PubMedGoogle Scholar
  81. 81.
    Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL et al (1990) Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70(2):519–527PubMedGoogle Scholar
  82. 82.
    Thompson JL, Butterfield GE, Marcus R, Hintz RL, Van Loan M, Ghiron L et al (1995) The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab 80(6):1845–1852PubMedGoogle Scholar
  83. 83.
    Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF et al (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323(1):1–6PubMedCrossRefGoogle Scholar
  84. 84.
    Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE et al (2002) Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. J Am Med Assoc 288(18):2282–2292Google Scholar
  85. 85.
    Giannoulis MG, Sonksen PH, Umpleby M, Breen L, Pentecost C, Whyte M et al (2006) The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab 91(2):477–484PubMedGoogle Scholar
  86. 86.
    Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR et al (1994) Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 79(5):1361–1366PubMedGoogle Scholar
  87. 87.
    Lange KH, Isaksson F, Juul A, Rasmussen MH, Bulow J, Kjaer M (2000) Growth hormone enhances effects of endurance training on oxidative muscle metabolism in elderly women. Am J Physiol Endocrinol Metab 279(5):E989–E996PubMedGoogle Scholar
  88. 88.
    Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M et al (1996) Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Internal Med 124(8):708–716Google Scholar
  89. 89.
    Taafe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR et al (1994) Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 79:1361–1366Google Scholar
  90. 90.
    Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D (1993) Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-1 concentrations. Clin Endocrinol 39:417–425Google Scholar
  91. 91.
    Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R (1994) Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 79(2):470–479PubMedGoogle Scholar
  92. 92.
    Ho KY, Weissberger AJ (1990) The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism 39(2):133–137PubMedGoogle Scholar
  93. 93.
    Welle S, Thornton C, Statt M, McHenry B (1996) Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J Clin Endocrinol Metab 81(9):3239–3243PubMedGoogle Scholar
  94. 94.
    Taaffe DR, Jin IH, Vu TH, Hoffman AR, Marcus R (1996) Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance-trained elderly men. J Clin Endocrinol Metab 81(1):421–425PubMedGoogle Scholar
  95. 95.
    Hennessey JV, Chromiak JA, DellaVentura S, Reinert SE, Puhl J, Kiel DP et al (2001) Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people. J Am Geriatr Soc 49(7):852–858PubMedGoogle Scholar
  96. 96.
    Weissberger AJ, Anastasiadis AD, Sturgess I, Martin FC, Smith MA, Sonksen PH (2003) Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement. Clin Endocrinol 58(1):99–107Google Scholar
  97. 97.
    Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson B (1996) Long term growth hormone treatment increases bone mineral content and density in patients with adult-onset growth hormone deficiency. J Clin Endocrinol Metab 81:2865–2873PubMedGoogle Scholar
  98. 98.
    Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM (1995) Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin Endocrinol 42:627–633Google Scholar
  99. 99.
    Drake WM, Howell SJ, Monson JP, Shalet SM (2001) Optimizing gh therapy in adults and children. Endocr Rev 22(4):425–450PubMedGoogle Scholar
  100. 100.
    Cohen P, Clemmons DR, Rosenfeld RG (2000) Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 10(6):297–305PubMedGoogle Scholar
  101. 101.
    Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA et al (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans Nature 389(6654):994–999PubMedGoogle Scholar
  102. 102.
    Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E et al (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292(5514):104–106PubMedGoogle Scholar
  103. 103.
    Flurkey K, Papaconstantinou J, Harrison DE (2002) The Snell dwarf mutation Pit1(dw) can increase life span in mice. Mech Ageing Dev 123(2–3):121–130PubMedGoogle Scholar
  104. 104.
    Brown-Borg HM, Borg KE, Meliska CJ, Bartke A (1996) Dwarf mice and the ageing process. Nature 384(6604):33PubMedGoogle Scholar
  105. 105.
    Rincon M, Rudin E, Barzilai N (2005) The insulin/IGF-1 signaling in mammals and its relevance to human longevity. Exp Gerontol 40(11):873–877PubMedGoogle Scholar
  106. 106.
    Flurkey K, Papaconstantinou J, Miller RA, Harrison DE (2001) Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 98(12):6736–6741PubMedGoogle Scholar
  107. 107.
    Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC et al (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421(6919):182–187PubMedGoogle Scholar
  108. 108.
    Bartke A (2003) Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78(4):210–216PubMedGoogle Scholar
  109. 109.
    Groesbeck MD, Parlow AF, Daughaday WH (1987) Stimulation of supranormal growth in prepubertal, adult plateaued, and hypophysectomized female rats by large doses of rat growth hormone: physiological effects and adverse consequences. Endocrinology 120(5):1963–1975PubMedGoogle Scholar
  110. 110.
    Laron Z (2005) Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? Mech Ageing Dev 126(2):305–307PubMedGoogle Scholar
  111. 111.
    Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS et al (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357(9254):425–431PubMedGoogle Scholar
  112. 112.
    Laron Z (2004) Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958–2003. J Clin Endocrinol Metab 89(3):1031–1044PubMedGoogle Scholar
  113. 113.
    Besson A, Salemi S, Gallati S, Jenal A, Horn R, Mullis PS et al (2003) Reduced longevity in untreated patients with isolated growth hormone deficiency. J Clin Endocrinol Metab 88(8):3664–3667PubMedGoogle Scholar
  114. 114.
    Toogood A, Jones J, O’Neill P, Thorner M, Shalet S (1998) The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease. Clin Endocrinol 48:569–576Google Scholar
  115. 115.
    Toogood AA (2004) Cardiovascular risk and mortality in patients with growth hormone deficiency. In: Abs R, Feldt-Rasmussen U (eds) Growth hormone deficiency in adults: 10 years of KIMS. 1st edn. Oxford Pharmagenesis, Oxford, pp 63–74Google Scholar
  116. 116.
    Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB et al (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children–2003 update. Endocr Pract 9(1):64–76PubMedGoogle Scholar
  117. 117.
    Yarasheski KE, Campbell JA, Kohrt WM (1997) Effect of resistance exercise and growth hormone on bone density in older men. Clin Endocrinol (Oxf) 47(2):223–229Google Scholar
  118. 118.
    Lange KH, Isaksson F, Rasmussen MH, Juul A, Bulow J, Kjaer M (2001) GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake. Clin Endocrinol (Oxf) 55(1):77–86Google Scholar
  119. 119.
    Munzer T, Harman SM, Hees P, Shapiro E, Christmas C, Bellantoni MF et al (2001) Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab 86(8):3604–3610PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Department of Endocrinology, Division of Medical SciencesUniversity of BirminghamEdgbastonEngland

Personalised recommendations